Understanding the behavior of very small breast tumors for better patient care
Mapping activeness of very small tumors in breast for patient stratification
This study is working on new imaging techniques to better understand tiny breast tumors, helping to tell which ones need urgent treatment and which ones don’t, so patients can avoid unnecessary procedures and worry.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Arlington NIH-funded |
| Lab location | 1 site (Arlington, United States) |
| Project ID | NIH-10114533 on NIH RePORTER |
What this research studies
This research focuses on improving the diagnosis and treatment of very small breast tumors, which are often difficult to assess using traditional imaging techniques. By developing advanced imaging technologies, the project aims to distinguish between aggressive and non-aggressive tumors, potentially reducing unnecessary biopsies and anxiety for patients. The study will analyze the activeness of tumors smaller than 10 mm, helping to stratify patients based on their specific cancer characteristics. This approach seeks to enhance patient outcomes by ensuring that only those with aggressive tumors receive immediate treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with very small breast tumors (stage T1a or T1b) who are facing uncertainty regarding the aggressiveness of their condition.
Not a fit: Patients with larger breast tumors or those who do not have breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and tailored treatment plans for patients with very small breast tumors.
How similar studies have performed: While there has been progress in breast cancer imaging, this specific approach to evaluating very small tumors is relatively novel and has not been extensively tested.
Where this research is happening
Arlington, United States
- University of Texas Arlington — Arlington, United States (Active)
Researchers
- Principal investigator: Yuan, Baohong — University of Texas Arlington
- Study coordinator: Yuan, Baohong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.